DiaMedica Therapeutics Inc (DMAC NASDAQ) stock market data APIs
$7.0031
0.04(0.6%)
as of September 15, 2025
Try our APIs with
free plan!
DiaMedica Therapeutics Inc Financial Data Overview
Price chart is built with
Anychart
DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, focuses on improving the lives of people suffering from severe ischemic diseases. Its lead candidate is DM199, a pharmaceutically active recombinant form of the human tissue kallikrein-1 protein, which is in Phase 2/3 trials for the treatment of acute ischemic stroke, as well as in Phase 2 to treat preeclampsia, cardio renal disease, and fetal growth restriction. The company also develops DM300, which is a recombinant human ulinastatin in the preclinical stage for the treatment of inflammatory diseases, such as acute pancreatitis. The company was formerly known as DiaMedica Inc. and changed its name to DiaMedica Therapeutics Inc. in December 2016. DiaMedica Therapeutics Inc. was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.
Prev. Close
7.0031
Open
7.0465
High
7.3538
Low
7.0031
52 wk Range
3.19-7.4899
Market Cap
366 M
Shares Outstanding
51 689 K
EPS
-0.18
Beta
1.399
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with DiaMedica Therapeutics Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get DiaMedica Therapeutics Inc data using free add-ons & libraries
Get DiaMedica Therapeutics Inc Fundamental Data
DiaMedica Therapeutics Inc Fundamental data includes:
- Net Revenue:
- EBITDA: -31 418 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-12
- EPS/Forecast: -0.19
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
DiaMedica Therapeutics Inc News
New
DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Reports Q2 2025 Earnings: Narrower Loss and Promising Clinical Updates Drive Stock Surge
DiaMedica Therapeutics Inc. (NASDAQ:DMAC [https://www.chartmill.com/stock/quote/DMAC]) reported its second-quarter 2025 financial results, posting a net loss of $7.7 million, or $0.18 per share, compa...
DiaMedica therapeutics (DMAC): Trill AB buys $5.4m in shares
Trill AB, a ten percent owner of DiaMedica Therapeutics Inc (NASDAQ:DMAC), reported purchasing 1,542,857 common shares of the company on July 23, 2025. The shares were bought at a price of $3.5, total...
DiaMedica therapeutics (DMAC) shareholder TomEnterprise Private AB buys $10M in stock
A 10% owner, TomEnterprise Private AB, associated with Thomas Von Koch, reported purchasing 2,857,142 shares of DiaMedica Therapeutics Inc. (NASDAQ:DMAC) common stock on July 23, 2025. The shares were...
DiaMedica Therapeutics raises $30 million in private placement
* DiaMedica Therapeutics (NASDAQ:DMAC [https://seekingalpha.com/symbol/DMAC]) announced on Monday definitive agreements for a $30.1 million private placement of common shares led by current investor...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
